Reveleer has introduced a groundbreaking AI-driven technology designed to enhance risk adjustment processes with real-time insights, improved coding accuracy, and automated workflows.
Revolutionizing Risk Adjustment with AI
As healthcare payers and providers face increasing regulatory complexities, precise risk adjustment is more critical than ever. Reveleer’s latest innovation streamlines medical record reviews (MRR) while ensuring compliance and financial optimization. By leveraging its proprietary AI-powered Evidence Validation Engine (EVE), the platform delivers predictive clinical insights with an accuracy rate of up to 99%.
Key Features of Reveleer’s Next-Gen AI Solution
- AI-Powered Clinical Review: Advanced algorithms enhance coding precision, reducing errors and improving risk adjustment factor (RAF) capture.
- Dynamic HCC Validation: Real-time validation accelerates efficiency while maintaining compliance and minimizing audit risks.
- Seamless Collaboration Tools: Integrated audit logs, annotations, and in-app messaging streamline workflow coordination.
- Comprehensive Member View: A holistic patient profile enables more informed clinical decisions and accurate coding.
- Optimized User Experience: Features like dual-screen support, bulk actions, and dark mode enhance productivity and reduce cognitive load.
Driving Efficiency with Cutting-Edge Automation
Reveleer processed over 1.1 billion medical chart pages in 2024, identifying 2.5 million diagnoses. The company’s investment in intelligent automation has helped reduce coding time by up to 42.5%, significantly improving operational efficiency.
Addressing the Challenges of Value-Based Care
The evolving landscape of value-based care requires innovative solutions to ensure financial sustainability. Reveleer’s AI-powered platform eliminates inefficiencies associated with manual risk adjustment processes, offering a seamless, accurate, and scalable solution.
Looking Ahead: Innovation in Risk Adjustment
“Retrospective risk adjustment is vital for the financial health of value-based care models, yet traditional approaches are fragmented and error-prone,” said Jay Ackerman, CEO of Reveleer. “Our latest AI-driven risk solution is just the beginning of how we plan to drive the future of value-based care.”
Experience the Future of Risk Adjustment
Reveleer will showcase its cutting-edge risk solution at RISE National, an industry-leading event taking place from March 11–13, 2025, in San Antonio, TX. Attendees can explore this innovative platform along with Reveleer’s suite of quality and clinical intelligence solutions.
For more details on Reveleer’s platform and solutions, visit www.reveleer.com.
